| Date Initiated by Firm | November 17, 2011 |
| Date Posted | January 11, 2012 |
| Recall Status1 |
Terminated 3 on January 09, 2012 |
| Recall Number | Z-0453-2012 |
| Recall Event ID |
60481 |
| 510(K)Number | K082140 K101879 |
| Product Classification |
in vitro diagnostic MRSA - Product Code NQX
|
| Product | Cepheid brand Xpert MRSA/SA-BC US-IVD, an In-vitro diagnostic test kit, Catalog Numbers: GXMRSA/SA-BC-10, Lots Affected: 2803 and 3001; |
| Code Information |
Lots affected: 2803 and 3001 |
| FEI Number |
3004530258
|
Recalling Firm/ Manufacturer |
Cepheid 904 E Caribbean Dr Sunnyvale CA 94089-1189
|
| For Additional Information Contact | Judith A Howard 408-541-4191 |
Manufacturer Reason for Recall | Cepheid has received reports from some of its customers regarding higher than desired (>5%) rates of invalid results when using lot numbers 2803 and 3001 of the Xpert MRSA/SA BC (blood culture) product. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | On 11/17/11, Cepheid issued letters via mail to all its direct consignees, informing them of the affected products and providing instructions on the recall. |
| Quantity in Commerce | 1289 |
| Distribution | Product was released for distribution in US. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = NQX
|